Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
14
Number of overlapping holdings
28.0%
% of FTXH's 51 holdings also in IHE
40.0%
% of IHE's 35 holdings also in FTXH
Overlap by Weight
Sector Drift (FTXH minus IHE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in FTXH |
Weight in IHE |
Overlap | |
---|---|---|---|---|
JOHNSON & JOHNSON | 6.9% | 22.2% | 6.9% | |
PFIZER INC | 7.4% | 4.6% | 4.6% | |
MERCK & CO. INC. | 7.0% | 4.6% | 4.6% | |
BRISTOL-MYERS SQUIBB CO | 7.3% | 4.4% | 4.4% | |
ELI LILLY & CO | 3.7% | 22.5% | 3.7% |
Position Highlights (Non-Overlapping Exposures)
FTXH Overweight Relative to IHE
ABBVIE INC | 7.3% | |
AMGEN INC | 3.6% | |
GILEAD SCIENCES INC | 3.6% | |
BIOGEN IDEC INC | 3.6% | |
REGENERON PHARMACEUTICALS | 3.6% | |
CARDINAL HEALTH INC | 3.6% | |
VERTEX PHARMACEUTICALS INC | 3.5% | |
UNITED THERAPEUTICS CORP | 3.4% | |
BRISTOL-MYERS SQUIBB CO | 2.9% | |
PFIZER INC | 2.8% |
FTXH Underweight Relative to IHE
ELI LILLY & CO | -18.8% | |
JOHNSON & JOHNSON | -15.3% | |
ROYALTY PHARMA PLC CLASS A | -4.6% | |
CATALENT INC | -4.0% | |
ELANCO ANIMAL HEALTH, INC. | -2.3% | |
INTRA-CELLULAR THERAPIES INC | -2.0% | |
CYMABAY THERAPEUTICS, INC. | -1.4% | |
AXSOME THERAPEUTICS, INC. | -1.3% | |
ZOETIS INC | -1.1% | |
VIATRIS, INC. | -1.0% |